FDA Moves to Reevaluate Several Peptides American Med Spa Association Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law FDA mulls compounding for peptides previously flagged over safety risks BioSpace BPC 157: is this a supplement I should be taking to improve my healing? Plano Orthopedic & Sports Medicine Center The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York